HK1182452A1 - 用於診斷病狀的方法和組合物 - Google Patents

用於診斷病狀的方法和組合物

Info

Publication number
HK1182452A1
HK1182452A1 HK13109866.7A HK13109866A HK1182452A1 HK 1182452 A1 HK1182452 A1 HK 1182452A1 HK 13109866 A HK13109866 A HK 13109866A HK 1182452 A1 HK1182452 A1 HK 1182452A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
diagnosing conditions
diagnosing
conditions
Prior art date
Application number
HK13109866.7A
Other languages
English (en)
Inventor
．肯尼迪
．丘多瓦
．威爾德
詹姆斯．
．維奇
邦妮．
．安德森
Original Assignee
威拉賽特公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 威拉賽特公司 filed Critical 威拉賽特公司
Publication of HK1182452A1 publication Critical patent/HK1182452A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Evolutionary Computation (AREA)
  • Databases & Information Systems (AREA)
  • Software Systems (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Epidemiology (AREA)
HK13109866.7A 2010-05-11 2013-08-22 用於診斷病狀的方法和組合物 HK1182452A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33371710P 2010-05-11 2010-05-11
US38981010P 2010-10-05 2010-10-05
PCT/US2011/036143 WO2011143361A2 (en) 2010-05-11 2011-05-11 Methods and compositions for diagnosing conditions

Publications (1)

Publication Number Publication Date
HK1182452A1 true HK1182452A1 (zh) 2013-11-29

Family

ID=44914969

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13109866.7A HK1182452A1 (zh) 2010-05-11 2013-08-22 用於診斷病狀的方法和組合物

Country Status (5)

Country Link
US (1) US20110312520A1 (zh)
EP (1) EP2569626B1 (zh)
CN (2) CN103038635B (zh)
HK (1) HK1182452A1 (zh)
WO (1) WO2011143361A2 (zh)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
EP2806054A1 (en) 2008-05-28 2014-11-26 Genomedx Biosciences Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
EP2427575B1 (en) 2009-05-07 2018-01-24 Veracyte, Inc. Methods for diagnosis of thyroid conditions
MX338694B (es) 2009-11-30 2016-04-27 Genentech Inc Composiciones y metodos para el diagnostico y el tratamiento de tumores.
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US8945829B2 (en) 2011-03-22 2015-02-03 Cornell University Distinguishing benign and malignant indeterminate thyroid lesions
US8744172B2 (en) * 2011-06-15 2014-06-03 Siemens Aktiengesellschaft Image processing using random forest classifiers
US20130023431A1 (en) * 2011-07-20 2013-01-24 Predictive Biosciences, Inc. Methods of Assessing Chromosomal Instabilities
US10513737B2 (en) 2011-12-13 2019-12-24 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
CA2881627A1 (en) 2012-08-16 2014-02-20 Genomedx Biosciences Inc. Cancer diagnostics using biomarkers
US20140058681A1 (en) * 2012-08-21 2014-02-27 Real Time Genomics, Inc. Methods for joint calling of biological sequences
WO2014052930A2 (en) * 2012-09-28 2014-04-03 The Regents Of The University Of California, Irvine Biomarkers for prostate cancer prognosis
KR101993716B1 (ko) * 2012-09-28 2019-06-27 삼성전자주식회사 카테고리별 진단 모델을 이용한 병변 진단 장치 및 방법
EP2923203B1 (en) * 2012-11-20 2018-10-03 The United States of America, as represented by The Secretary, Department of Health and Human Services Assay to measure midkine or pleiotrophin level for diagnosing a growth
EP2925886B1 (en) 2012-11-27 2019-04-24 Pontificia Universidad Católica de Chile Compositions and methods for diagnosing thyroid tumors
EP2968988A4 (en) 2013-03-14 2016-11-16 Allegro Diagnostics Corp METHOD FOR EVALUATING A COPD STATUS
CN105378104A (zh) * 2013-03-15 2016-03-02 威拉赛特公司 用于样品分类的方法和组合物
CN105247075B (zh) * 2013-03-15 2019-02-15 威拉赛特公司 用于诊断肺病的生物标记物及其使用方法
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US11293064B2 (en) 2013-05-02 2022-04-05 Thomas Jefferson University Human miRNAs for use in diagnosis, prognosis, and therapy of human conditions and diseases
US11337612B2 (en) * 2013-12-03 2022-05-24 Children's National Medical Center Method and system for wound assessment and management
US11213220B2 (en) 2014-08-11 2022-01-04 Cubisme, Inc. Method for determining in vivo tissue biomarker characteristics using multiparameter MRI matrix creation and big data analytics
EP3215170A4 (en) 2014-11-05 2018-04-25 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
EP3034620A1 (en) * 2014-12-17 2016-06-22 Diaxonhit Compositions and methods for diagnosing thyroid cancer
CA2978442A1 (en) * 2015-03-04 2016-09-09 Veracyte, Inc. Methods for assessing the risk of disease occurrence or recurrence using expression level and sequence variant information
SG11201707067UA (en) * 2015-03-12 2017-09-28 Agency Science Tech & Res A multigene assay
WO2016179814A1 (zh) * 2015-05-13 2016-11-17 广州赫尔氏药物开发有限公司 与乳头状甲状腺瘤相关的基因
US9922433B2 (en) 2015-05-29 2018-03-20 Moira F. Schieke Method and system for identifying biomarkers using a probability map
CN105288659B (zh) * 2015-06-01 2019-07-26 北京泱深生物信息技术有限公司 Tenm1基因及其表达产物在诊治乳头状腺癌的应用
MA42294B1 (fr) 2015-07-01 2020-11-30 Immatics Biotechnologies Gmbh Nouveaux peptides et combinaison de peptides à utiliser en immunothérapie contre le cancer de l'ovaire et d'autres cancers
GB201511546D0 (en) 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
CN105483245B (zh) * 2015-12-29 2020-02-11 成都诺恩基因科技有限公司 一种区分反应性淋巴结节增生与淋巴瘤的miRNA测定方法
US20200216900A1 (en) * 2016-02-17 2020-07-09 Icahn School Of Medicine At Mount Sinai Nasal biomarkers of asthma
US10776963B2 (en) 2016-07-01 2020-09-15 Cubismi, Inc. System and method for forming a super-resolution biomarker map image
IT201600069927A1 (it) * 2016-07-05 2018-01-05 Fondazione Univ Niccolò Cusano Per La Ricerca Medico Scientifica Metodo per la diagnosi in vitro di carcinoma tiroideo.
EP3504348B1 (en) 2016-08-24 2022-12-14 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
EP3346000A1 (de) * 2017-01-05 2018-07-11 co.don AG Verfahren zur selektion von bandscheibenzellen
US11208697B2 (en) 2017-01-20 2021-12-28 Decipher Biosciences, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
WO2018165600A1 (en) 2017-03-09 2018-09-13 Genomedx Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
US11232853B2 (en) 2017-04-21 2022-01-25 Cubisme, Inc. System and method for creating, querying, and displaying a MIBA master file
US11078542B2 (en) 2017-05-12 2021-08-03 Decipher Biosciences, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
US10529453B2 (en) 2017-07-31 2020-01-07 Definiens Gmbh Tool that analyzes image data and generates and displays a confidence indicator along with a cancer score
CN107988366B (zh) * 2017-12-22 2020-07-14 深圳市宝安区妇幼保健院 一种用于诊断评估乳腺癌的试剂盒、甲基化hoxa4/dpp6基因的检测及其应用
CN108335756B (zh) * 2018-01-18 2022-05-24 中山大学 鼻咽癌数据库及基于所述数据库的综合诊疗决策方法
CA3097992A1 (en) * 2018-04-24 2019-10-31 Grail, Inc. Systems and methods for using pathogen nucleic acid load to determine whether a subject has a cancer condition
CN109035269B (zh) * 2018-07-03 2021-05-11 怀光智能科技（武汉）有限公司 一种宫颈细胞病理切片病变细胞分割方法及系统
CN109762902B (zh) * 2018-07-27 2022-07-05 四川大学华西医院 一种人类map2k5第1100位碱基突变基因的arms-pcr检测试剂盒
CN109652552B (zh) * 2018-07-27 2022-07-05 四川大学华西医院 一种人类map2k5第961位碱基突变基因的arms-pcr检测试剂盒
EP3657391B1 (en) * 2018-11-21 2023-07-26 Siemens Healthcare GmbH Processing a medical image
CN109457032B (zh) * 2018-12-20 2022-04-12 北京优迅医学检验实验室有限公司 甲状腺癌分子诊断试剂盒
CN110841068A (zh) * 2019-12-13 2020-02-28 宁夏医科大学总医院 Src酪氨酸激酶抑制剂在抑制炎症因子分泌中的应用
CN111460173B (zh) * 2019-12-26 2023-02-03 四川大学华西医院 一种甲状腺癌的疾病本体模型的构建方法
CN111139300B (zh) * 2020-02-19 2021-08-17 伯克利南京医学研究有限责任公司 一组结肠癌预后相关基因的应用
CN112557668B (zh) * 2020-08-21 2022-06-10 北京信诺卫康科技有限公司 免疫相关不良反应的标志物及其应用
EP4023770A1 (en) 2021-01-05 2022-07-06 Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Oddzial w Gliwicach A method of examining genes for the diagnosis of thyroid tumors, a set for the diagnosis of thyroid tumors and application
CN112863605A (zh) * 2021-02-03 2021-05-28 中国人民解放军总医院第七医学中心 一种确定智力障碍基因的平台、方法、计算机设备和介质
CN115128285B (zh) * 2022-08-30 2023-01-06 西湖大学 一种蛋白质组合对甲状腺滤泡性肿瘤鉴别评估的试剂盒、系统
CN116183920B (zh) * 2022-09-22 2023-10-20 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 用于检测鼻咽癌预后的抗体组合、系统及应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT277936B (de) 1968-02-27 1970-01-12 Guenter Dipl Ing Knapp Verfahren zur quantitativen Bestimmung von Jod und von Schilddrüsenhormonen sowie Vorrichtung zur Durchführung des Verfahrens
US5798257A (en) 1990-07-09 1998-08-25 Research Corporation Technologies, Inc. Nucleic acid encoding human MTS-1 protein
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
EP1460132A1 (en) 1998-06-08 2004-09-22 Fuso Pharmaceutical Industries Ltd. Antibodies with specific immunoreactivity to thyroid carcinoma cells
US6436642B1 (en) 1999-04-20 2002-08-20 Curagen Corporation Method of classifying a thyroid carcinoma using differential gene expression
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7361488B2 (en) 2000-02-07 2008-04-22 Illumina, Inc. Nucleic acid detection methods using universal priming
US6988040B2 (en) 2001-01-11 2006-01-17 Affymetrix, Inc. System, method, and computer software for genotyping analysis and identification of allelic imbalance
US20030190602A1 (en) 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
EP1440311B1 (en) 2001-08-31 2009-01-07 Gen-Probe Incorporated Affinity-shifted probes for quantifying analyte polynucleotides
US20030186248A1 (en) 2002-03-29 2003-10-02 Erlander Mark G. Interpreting cytological specimens via molecular histological signatures
US7300788B2 (en) 2002-10-08 2007-11-27 Affymetrix, Inc. Method for genotyping polymorphisms in humans
US20050266443A1 (en) 2002-10-11 2005-12-01 Thomas Jefferson University Novel tumor suppressor gene and compositions and methods for making and using the same
JP4425142B2 (ja) 2002-11-07 2010-03-03 洋一 松原 遺伝子変異検出法
EP2159285B1 (en) 2003-01-29 2012-09-26 454 Life Sciences Corporation Methods of amplifying and sequencing nucleic acids
US7378233B2 (en) 2003-04-12 2008-05-27 The Johns Hopkins University BRAF mutation T1796A in thyroid cancers
AU2004251256B2 (en) * 2003-05-30 2009-05-28 The Board Of Trustees Of The University Of Illinois Gene expression profiles that identify genetically elite ungulate mammals
CA2554818A1 (en) 2004-02-09 2005-08-25 Thomas Jefferson University Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
US7319011B2 (en) 2004-04-08 2008-01-15 Duke University Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC)
US7901881B2 (en) * 2004-04-09 2011-03-08 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic tool for diagnosing benign versus malignant thyroid lesions
WO2005118806A2 (en) 2004-05-28 2005-12-15 Ambion, Inc. METHODS AND COMPOSITIONS INVOLVING MicroRNA
CN101040056A (zh) 2004-06-04 2007-09-19 阿威亚拉德克斯股份有限公司 Hoxb13基因对癌症的重要性
US20060019615A1 (en) 2004-07-24 2006-01-26 Ditmer Larry R Wireless keying for a continuous wave (CW) amateur radio transmitter
WO2006020837A2 (en) 2004-08-11 2006-02-23 The Cleveland Clinic Foundation Method of detecting thyroid cancer
US7892540B2 (en) 2004-10-06 2011-02-22 Mayo Foundation For Medical Education And Research B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
US20070037186A1 (en) * 2005-05-20 2007-02-15 Yuqiu Jiang Thyroid fine needle aspiration molecular assay
US20070020657A1 (en) 2005-05-20 2007-01-25 Grebe Stefan K Methods for detecting circulating tumor cells
US7598052B2 (en) 2005-10-11 2009-10-06 The Regents Of The University Of Michigan Expression profile of thyroid cancer
JP4867018B2 (ja) 2006-03-22 2012-02-01 富士フイルム株式会社 癌の検出方法および抑制方法
US20080014584A1 (en) * 2006-06-01 2008-01-17 Mayo Foundation For Medical Education And Research Modulating androgen receptor activity
US20090191535A1 (en) * 2007-12-22 2009-07-30 Mark Carle Connelly Method of assessing metastatic carcinomas from circulating endothelial cells and disseminated tumor cells
WO2009140542A1 (en) * 2008-05-14 2009-11-19 Dnar, Inc. Biomarkers for the identification, monitoring, and treatment of head and neck cancer
GB2477705B (en) * 2008-11-17 2014-04-23 Veracyte Inc Methods and compositions of molecular profiling for disease diagnostics
WO2011116380A2 (en) * 2010-03-19 2011-09-22 H. Lee Moffitt Cancer Center And Research Institute, Inc. Hybrid model for the classification of carcinoma subtypes

Also Published As

Publication number Publication date
WO2011143361A2 (en) 2011-11-17
WO2011143361A3 (en) 2012-03-15
EP2569626A2 (en) 2013-03-20
EP2569626B1 (en) 2019-11-27
EP2569626A4 (en) 2014-04-02
US20110312520A1 (en) 2011-12-22
CN103038635A (zh) 2013-04-10
CN106498076A (zh) 2017-03-15
CN103038635B (zh) 2016-12-28

Similar Documents

Publication Publication Date Title
HK1246715A1 (zh) 用於靶向熱調節的組合物和方法
HK1182452A1 (zh) 用於診斷病狀的方法和組合物
EP2582846A4 (en) COMPOSITIONS AND METHODS FOR IDENTIFYING AND MODIFYING CARBON COMPOSITIONS
EP2566930A4 (en) COOLING COMPOSITIONS AND METHODS
EP2591359A4 (en) METHODS AND COMPOSITIONS FOR QUANTIFYING EXOSOMES
EP2742154A4 (en) BIOMARKER COMPOSITIONS AND METHODS
EP2721179A4 (en) BIOMARKER COMPOSITIONS AND ASSOCIATED METHODS
HK1202625A1 (zh) 評估闌尾炎的組合及方法
EP2539355A4 (en) POLYTAG PROBES
EP2629742A4 (en) HAIR CARE COMPOSITIONS AND RELATED METHODS
IL225547A0 (en) Preparations and methods for diagnosing autism
GB201010891D0 (en) Inspection
EP2561795A4 (en) PROBE
GB201008541D0 (en) Diagnostic methods
EP2533645A4 (en) METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS
GB201005624D0 (en) Probe
GB201016161D0 (en) Diagnostic method
GB201008719D0 (en) Diagnostic method
HK1201451A1 (zh) 組合物及其製備方法
GB201018650D0 (en) Methods and compositions
ZA201301498B (en) Diagnostic method
EP2603610A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING A LUPUS
GB2478399B (en) Toner compositions and methods
EP2633796A4 (en) PROBE
EP2643340A4 (en) COMPOSITIONS AND METHODS FOR FUNCTIONAL GLYCOMICS